Implant infections could be banished thanks to scaffold breakthrough

June 19, 2017, Institute of Physics
Escherichia coli. Credit: Rocky Mountain Laboratories, NIAID, NIH

Researchers in Ireland have taken a major step forward in the battle against medical implant infections.

They developed a new type of scaffold to provide localised drug treatment and prevent infection, which has already proven effective against two types of major problem bacteria.

Publishing their results today in the journal Biomedical Materials, the team from the National University of Ireland Galway show that stabilised collagen scaffolds loaded with a particular antibiotic were able to prevent both Escherichia coli and Staphylococcus epidermidis from forming.

Lead author Dr Dimitrios Zeugolis, from NUI Galway's Regenerative, Modular & Developmental Engineering Laboratory (REMODEL) and Science Foundation Ireland (SFI) Centre for Research in Medical Devices (CÚRAM), said: "Implant infections remain a major healthcare problem. They can require long hospitalisation periods to disturb and treat bacterial biofilm formation. There can also be a need for additional surgeries to remove or replace the infected implant, which if not done in time may lead to sepsis.

"Although localised drug treatment, via an implanted scaffold has shown promise, the ideal scaffold cross-linking (to initially withstand the aggressive infection environment) and (to fight against ) have not, until now, been found."

The team first developed a collagen scaffold, with a 0.625 per cent concentration of hexamethylene diisocyanate (HDI) used to stabilise it. They then tested the scaffolds with variable concentrations of the antibiotics Cefaclor and Ranalexin.

Dr Zeugolis said: "Both drugs showed similar loading efficiency, release profile and cytocompatibility. However, only collagen scaffolds loaded with 100 μg/ml of Cefaclor showed adequate antibacterial properties against both E-coli and Staphylococcus epidermidis.

"Our cross-linked marks an important step forward against a problem that is both a major health problem and a severe economic burden to healthcare systems internationally."

Explore further: Artificial cartilage under tension as strong as natural material

More information: E K Tsekoura et al, Battling bacterial infection with hexamethylene diisocyanate cross-linked and Cefaclor-loaded collagen scaffolds, Biomedical Materials (2017). DOI: 10.1088/1748-605X/aa6de0

Related Stories

Mesenchymal stem cells show promise for torn meniscus

December 22, 2016

(HealthDay)—Undifferentiated autologous mesenchymal stem cells (MSCs) seeded onto a collagen scaffold (MSC/collagen-scaffold) shows promise for patients with torn meniscus, according to a study published online Dec. 15 ...

Recommended for you

Organic crystals twist, bend, and heal

June 18, 2018

Crystals are brittle and inelastic? A novel class of smart, bendable crystalline organic materials has challenged this view. Now, scientists have engineered a molecular soft cocrystalline structure that bends and twists reversibly ...

Electrical wire properties of DNA linked to cancer

June 18, 2018

One of the biggest helpers in our bodies' ongoing efforts to prevent DNA mutations—mutations that can lead to cancer—is actually rather tiny. Electrons, as it turns out, can signal proteins that repair DNA to patch up ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.